Keyphrases
Netherlands
100%
Long-term Efficacy
100%
Human Papillomavirus Vaccine
100%
Vaccination
83%
Cervical Cancer
83%
Quality-adjusted Life Years
33%
High-risk Human Papillomavirus (HR-HPV)
33%
CIN2+
33%
Excisional Treatment
33%
Cancer Mortality
33%
Europe
16%
Negative Side Effects
16%
Effective Strategies
16%
Health Benefits
16%
Cancer Treatment
16%
Quality of Life
16%
12-year-olds
16%
Health Economic Outcomes
16%
Large Reduction
16%
Life-years Gained
16%
Loss of Life
16%
Markov Model
16%
Health Economic Model
16%
Cancer Cases
16%
Cervical Disease
16%
Cervical Intraepithelial Neoplasia Grade 2
16%
Excisional Procedure
16%
Bivalent Vaccine
16%
Precancer
16%
Cancer Disease
16%
Preterm Delivery
16%
Unvaccinated
16%
Treatment Side Effects
16%
Vaccination Coverage
16%
Medicine and Dentistry
Wart Virus
100%
Cervical Cancer
100%
Wart Virus Vaccine
60%
Disease
40%
Quality Adjusted Life Year
40%
Side Effect
40%
Cancer Mortality
40%
Quality of Life
20%
Lifespan
20%
Cervical Intraepithelial Neoplasia
20%
Precancerous Condition
20%
Premature Labor
20%
Vaccination Coverage
20%
Pharmacology, Toxicology and Pharmaceutical Science
Uterine Cervix Cancer
100%
Human Papillomavirus
100%
Wart Virus Vaccine
60%
Disease
40%
Side Effect
40%
Cancer Mortality
40%
Precancer
20%
Premature Labor
20%
Uterine Cervix Carcinoma in Situ
20%